-
2
-
-
84879199443
-
Role of hormones in cartilage and joint metabolism: Understanding an unhealthy metabolic phenotype in osteoarthritis
-
Bay-Jensen AC, Slagboom E, Chen-An P, Alexandersen P, Qvist P, Christiansen C, et al. Role of hormones in cartilage and joint metabolism: understanding an unhealthy metabolic phenotype in osteoarthritis. Menopause. 2013;20(5):578-86.
-
(2013)
Menopause
, vol.20
, Issue.5
, pp. 578-586
-
-
Bay-Jensen, A.C.1
Slagboom, E.2
Chen-An, P.3
Alexandersen, P.4
Qvist, P.5
Christiansen, C.6
-
3
-
-
84878237995
-
Why subchondral bone in osteoarthritis the importance of the cartilage bone interface in osteoarthritis
-
10.1007/s00198-012-2161-0
-
Mahjoub M, Berenbaum F, Houard X. Why subchondral bone in osteoarthritis? The importance of the cartilage bone interface in osteoarthritis. Osteoporos Int. 2012;23 Suppl 8:841-6.
-
(2012)
Osteoporos Int
, vol.23
, Issue.SUPPL. 8
, pp. 841-846
-
-
Mahjoub, M.1
Berenbaum, F.2
Houard, X.3
-
4
-
-
78049527698
-
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis
-
20924410 1:CAS:528:DC%2BC3cXhtlGkt7nI 10.1038/nrrheum.2010.159 Important review that highlights the role of synovitis in the pathophysiology of OA
-
• Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6(11):625-35. Important review that highlights the role of synovitis in the pathophysiology of OA.
-
(2010)
Nat Rev Rheumatol
, vol.6
, Issue.11
, pp. 625-635
-
-
Sellam, J.1
Berenbaum, F.2
-
5
-
-
5444259084
-
The regulation of chondrocyte function by proinflammatory mediators: Prostaglandins and nitric oxide
-
DOI 10.1097/01.blo.0000144484.69656.e4
-
Goldring MB, Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res. 2004;(427 Suppl):S37-46. (Pubitemid 39362799)
-
(2004)
Clinical Orthopaedics and Related Research
, Issue.427 SUPPL.
-
-
Goldring, M.B.1
Berenbaum, F.2
-
6
-
-
84871252069
-
Osteoarthritis, inflammation and obesity
-
23090672 1:CAS:528:DC%2BC38XhslKgsbvO 10.1097/BOR.0b013e32835a9414
-
Berenbaum F, Eymard F, Houard X. Osteoarthritis, inflammation and obesity. Curr Opin Rheumatol. 2013;25(1):114-8.
-
(2013)
Curr Opin Rheumatol
, vol.25
, Issue.1
, pp. 114-118
-
-
Berenbaum, F.1
Eymard, F.2
Houard, X.3
-
7
-
-
84870696930
-
Metabolic syndrome meets osteoarthritis
-
22907293 1:CAS:528:DC%2BC38XhslKgtLjM 10.1038/nrrheum.2012.135
-
Zhuo Q, Yang W, Chen J, Wang Y. Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol. 2012;8(12):729-37.
-
(2012)
Nat Rev Rheumatol
, vol.8
, Issue.12
, pp. 729-737
-
-
Zhuo, Q.1
Yang, W.2
Chen, J.3
Wang, Y.4
-
8
-
-
77954439908
-
Osteoarthritis in women: Effects of estrogen, obesity and physical activity
-
10.2217/whe.10.38
-
Stevens-Lapsley JE, Kohrt WM. Osteoarthritis in women: effects of estrogen, obesity and physical activity. Womens Health (Lond Engl). 2010;6(4):601-15.
-
(2010)
Womens Health (Lond Engl)
, vol.6
, Issue.4
, pp. 601-615
-
-
Stevens-Lapsley, J.E.1
Kohrt, W.M.2
-
9
-
-
84861827675
-
Osteoarthritis: A disease of the joint as an organ
-
22392533 10.1002/art.34453 This recent review highlights the fact that OA is a disease of the whole joint as an organ
-
• Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64(6):1697-707. This recent review highlights the fact that OA is a disease of the whole joint as an organ.
-
(2012)
Arthritis Rheum
, vol.64
, Issue.6
, pp. 1697-1707
-
-
Loeser, R.F.1
Goldring, S.R.2
Scanzello, C.R.3
Goldring, M.B.4
-
10
-
-
80052030972
-
Aging and osteoarthritis
-
21709557 1:CAS:528:DC%2BC3MXhtVaksbvI 10.1097/BOR.0b013e3283494005
-
Loeser RF. Aging and osteoarthritis. Curr Opin Rheumatol. 2011;23(5):492-6.
-
(2011)
Curr Opin Rheumatol
, vol.23
, Issue.5
, pp. 492-496
-
-
Loeser, R.F.1
-
11
-
-
84871226206
-
Aging processes and the development of osteoarthritis
-
23080227 10.1097/BOR.0b013e32835a9428 This very recent review discusses the role of aging in the development of OA
-
• Loeser RF. Aging processes and the development of osteoarthritis. Curr Opin Rheumatol. 2013;25(1):108-13. This very recent review discusses the role of aging in the development of OA.
-
(2013)
Curr Opin Rheumatol
, vol.25
, Issue.1
, pp. 108-113
-
-
Loeser, R.F.1
-
12
-
-
67650383738
-
Aging and osteoarthritis: The role of chondrocyte senescence and aging changes in the cartilage matrix
-
19303469 1:STN:280:DC%2BD1MvptFWgsg%3D%3D 10.1016/j.joca.2009.03.002
-
Loeser RF. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthr Cartil. 2009;17(8):971-9.
-
(2009)
Osteoarthr Cartil
, vol.17
, Issue.8
, pp. 971-979
-
-
Loeser, R.F.1
-
13
-
-
77949881221
-
The senescence-associated secretory phenotype: The dark side of tumor suppression
-
20078217 1:CAS:528:DC%2BC3cXivFekt70%3D 10.1146/annurev-pathol-121808- 102144 This article outlines the senescence-associated secretory phenotype of tumor cells
-
•• Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99-118. This article outlines the senescence-associated secretory phenotype of tumor cells.
-
(2010)
Annu Rev Pathol
, vol.5
, pp. 99-118
-
-
Coppe, J.P.1
Desprez, P.Y.2
Krtolica, A.3
Campisi, J.4
-
14
-
-
60549090080
-
Developments in the clinical understanding of osteoarthritis
-
19232065 10.1186/ar2531
-
Felson DT. Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther. 2009;11(1):203.
-
(2009)
Arthritis Res Ther
, vol.11
, Issue.1
, pp. 203
-
-
Felson, D.T.1
-
15
-
-
77953939679
-
The role of acetaminophen in the treatment of osteoarthritis
-
20297877
-
Flood J. The role of acetaminophen in the treatment of osteoarthritis. Am J Manag Care. 2010;16(Suppl Management):S48-54.
-
(2010)
Am J Manag Care
, vol.16
, Issue.SUPPL MANAGEMENT
-
-
Flood, J.1
-
17
-
-
0033093793
-
Role of cyclooxygenase-1 and -2 in health and disease
-
1:STN:280:DyaK1M3gvVensg%3D%3D
-
Lipsky PE. Role of cyclooxygenase-1 and -2 in health and disease. Am J Orthop (Belle Mead NJ). 1999;28(3 Suppl):8-12.
-
(1999)
Am J Orthop (Belle Mead NJ)
, vol.28
, Issue.3 SUPPL.
, pp. 8-12
-
-
Lipsky, P.E.1
-
18
-
-
0032579890
-
Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury
-
DOI 10.1016/S0002-9343(97)00207-6, PII S0002934398002076
-
Griffin MR. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury. Am J Med. 1998;104(3A):23S-9S. discussion 41S-2S. (Pubitemid 28186991)
-
(1998)
American Journal of Medicine
, vol.104
, Issue.3
-
-
Griffin, M.R.1
-
19
-
-
0030983255
-
Meloxicam: Selective COX-2 inhibition in clinical practice
-
Furst DE. Meloxicam: selective COX-2 inhibition in clinical practice. Semin Arthritis Rheum. 1997;26(6 Suppl 1):21-7. (Pubitemid 27274439)
-
(1997)
Seminars in Arthritis and Rheumatism
, vol.26
, Issue.6 SUPPL. 1
, pp. 21-27
-
-
Furst, D.E.1
-
20
-
-
22144482038
-
COX-2 selective inhibitors in the treatment of arthritis: A rheumatologist perspective
-
DOI 10.2174/1568026054201695
-
Hochberg MC. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective. Curr Top Med Chem. 2005;5(5):443-8. (Pubitemid 40974816)
-
(2005)
Current Topics in Medicinal Chemistry
, vol.5
, Issue.5
, pp. 443-448
-
-
Hochberg, M.C.1
-
21
-
-
0034885576
-
Aceclofenac: A reappraisal of its use in the management of pain and rheumatic disease
-
Dooley M, Spencer CM, Dunn CJ. Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease. Drugs. 2001;61(9):1351-78. (Pubitemid 32744414)
-
(2001)
Drugs
, vol.61
, Issue.9
, pp. 1351-1378
-
-
Dooley, M.1
Spencer, C.M.2
Dunn, C.J.3
-
22
-
-
17044416539
-
Review of the selective COX-2 inhibitors celecoxib and rofecoxib: Focus on clinical aspects
-
17608990
-
Loewen PS. Review of the selective COX-2 inhibitors celecoxib and rofecoxib: focus on clinical aspects. CJEM. 2002;4(4):268-75.
-
(2002)
CJEM
, vol.4
, Issue.4
, pp. 268-275
-
-
Loewen, P.S.1
-
23
-
-
34548548907
-
OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence
-
DOI 10.1016/j.joca.2007.06.014, PII S1063458407002348
-
Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthr Cartil. 2007;15(9):981-1000. (Pubitemid 47393443)
-
(2007)
Osteoarthritis and Cartilage
, vol.15
, Issue.9
, pp. 981-1000
-
-
Zhang, W.1
Moskowitz, R.W.2
Nuki, G.3
Abramson, S.4
Altman, R.D.5
Arden, N.6
Bierma-Zeinstra, S.7
Brandt, K.D.8
Croft, P.9
Doherty, M.10
Dougados, M.11
Hochberg, M.12
Hunter, D.J.13
Kwoh, K.14
Lohmander, L.S.15
Tugwell, P.16
-
24
-
-
84861980210
-
Osteochondral alterations in osteoarthritis
-
22023932 10.1016/j.bone.2011.10.010
-
Suri S, Walsh DA. Osteochondral alterations in osteoarthritis. Bone. 2012;51(2):204-11.
-
(2012)
Bone
, vol.51
, Issue.2
, pp. 204-211
-
-
Suri, S.1
Walsh, D.A.2
-
25
-
-
36448997363
-
Vascular pathology and osteoarthritis
-
DOI 10.1093/rheumatology/kem191
-
Findlay DM. Vascular pathology and osteoarthritis. Rheumatology (Oxford). 2007;46(12):1763-8. (Pubitemid 350168289)
-
(2007)
Rheumatology
, vol.46
, Issue.12
, pp. 1763-1768
-
-
Findlay, D.M.1
-
26
-
-
84455202518
-
Subchondral bone as a key target for osteoarthritis treatment
-
21964345 1:CAS:528:DC%2BC3MXhs1OqsrvJ 10.1016/j.bcp.2011.09.018
-
Castaneda S, Roman-Blas JA, Largo R, Herrero-Beaumont G. Subchondral bone as a key target for osteoarthritis treatment. Biochem Pharmacol. 2012;83(3):315-23.
-
(2012)
Biochem Pharmacol
, vol.83
, Issue.3
, pp. 315-323
-
-
Castaneda, S.1
Roman-Blas, J.A.2
Largo, R.3
Herrero-Beaumont, G.4
-
27
-
-
77950659332
-
Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis
-
20392241 1:CAS:528:DC%2BC3cXmsVSrtrY%3D 10.1111/j.1749-6632.2009.05240.x This review article focuses on the specific articular cartilage and skeletal features of OA and the putative mechanisms involved in their pathogenesis
-
• Goldring MB, Goldring SR. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci. 2010;1192:230-7. This review article focuses on the specific articular cartilage and skeletal features of OA and the putative mechanisms involved in their pathogenesis.
-
(2010)
Ann N y Acad Sci
, vol.1192
, pp. 230-237
-
-
Goldring, M.B.1
Goldring, S.R.2
-
28
-
-
1542752189
-
Anatomy and physiology of the mineralized tissues: Role in the pathogenesis of osteoarthrosis
-
DOI 10.1016/j.joca.2003.09.016, PII S1063458403002553, The Role of Bone in the Treatment of Osteoarthritis
-
Burr DB. Anatomy and physiology of the mineralized tissues: role in the pathogenesis of osteoarthrosis. Osteoarthr Cartil. 2004;12(Suppl A):S20-30. (Pubitemid 38950273)
-
(2004)
Osteoarthritis and Cartilage
, vol.12
, Issue.SUPLL.
-
-
Burr, D.B.1
-
29
-
-
57049156113
-
How close are we to having structure-modifying drugs available?
-
19059031 1:CAS:528:DC%2BD1MXhsFCju7k%3D 10.1016/j.mcna.2008.07.011 xiii
-
Hunter DJ, Hellio Le Graverand-Gastineau MP. How close are we to having structure-modifying drugs available? Med Clin N Am. 2009;93(1):223-34. xiii.
-
(2009)
Med Clin N Am
, vol.93
, Issue.1
, pp. 223-234
-
-
Hunter, D.J.1
Hellio Le Graverand-Gastineau, M.P.2
-
30
-
-
48349087951
-
How close are we to having structure-modifying drugs available?
-
10.1016/j.rdc.2008.05.003
-
Hunter DJ, Hellio Le Graverand-Gastineau MP. How close are we to having structure-modifying drugs available? Rheum Dis Clin N Am. 2008;34(3):789-802.
-
(2008)
Rheum Dis Clin N Am
, vol.34
, Issue.3
, pp. 789-802
-
-
Hunter, D.J.1
Hellio Le Graverand-Gastineau, M.P.2
-
31
-
-
66149180583
-
Developments in the scientific understanding of osteoarthritis
-
19519925 10.1186/ar2655
-
Abramson SB, Attur M. Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther. 2009;11(3):227.
-
(2009)
Arthritis Res Ther
, vol.11
, Issue.3
, pp. 227
-
-
Abramson, S.B.1
Attur, M.2
-
32
-
-
78650975710
-
The bone-cartilage unit in osteoarthritis
-
21135881 1:CAS:528:DC%2BC3MXht1Giug%3D%3D 10.1038/nrrheum.2010.197 This paper focuses on the functional unit formed by articular cartilage and subchondral bone in the context of OA
-
• Lories RJ, Luyten FP. The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol. 2011;7(1):43-9. This paper focuses on the functional unit formed by articular cartilage and subchondral bone in the context of OA.
-
(2011)
Nat Rev Rheumatol
, vol.7
, Issue.1
, pp. 43-49
-
-
Lories, R.J.1
Luyten, F.P.2
-
33
-
-
80053983922
-
Bisphosphonates for osteoarthritis
-
21996085 1:CAS:528:DC%2BC3MXhtl2mt7fP 10.1186/ar3448
-
Walsh DA, Chapman V. Bisphosphonates for osteoarthritis. Arthritis Res Ther. 2011;13(5):128.
-
(2011)
Arthritis Res Ther
, vol.13
, Issue.5
, pp. 128
-
-
Walsh, D.A.1
Chapman, V.2
-
34
-
-
0033762970
-
Pathogenesis of osteoporosis
-
11035901 1:STN:280:DC%2BD3M%2FjsFehuw%3D%3D 10.1053/beem.2000.0068
-
Rosen CJ. Pathogenesis of osteoporosis. Baillieres Best Pract Res Clin Endocrinol Metab. 2000;14(2):181-93.
-
(2000)
Baillieres Best Pract Res Clin Endocrinol Metab
, vol.14
, Issue.2
, pp. 181-193
-
-
Rosen, C.J.1
-
35
-
-
84868510906
-
Bone remodelling in osteoarthritis
-
Burr DB, Gallant MA. Bone remodelling in osteoarthritis. Nat Rev Rheumatol. 2012;8(11):665-73.
-
(2012)
Nat Rev Rheumatol
, vol.8
, Issue.11
, pp. 665-673
-
-
Burr, D.B.1
Gallant, M.A.2
-
36
-
-
77950434451
-
The association between subchondral bone cysts and tibial cartilage volume and risk of joint replacement in people with knee osteoarthritis: A longitudinal study
-
20356405 10.1186/ar2971
-
Tanamas SK, Wluka AE, Pelletier JP, Martel-Pelletier J, Abram F, Wang Y, et al. The association between subchondral bone cysts and tibial cartilage volume and risk of joint replacement in people with knee osteoarthritis: a longitudinal study. Arthritis Res Ther. 2010;12(2):R58.
-
(2010)
Arthritis Res Ther
, vol.12
, Issue.2
, pp. 58
-
-
Tanamas, S.K.1
Wluka, A.E.2
Pelletier, J.P.3
Martel-Pelletier, J.4
Abram, F.5
Wang, Y.6
-
37
-
-
77952688579
-
If good things come from above, do bad things come from below?
-
20519029 10.1186/ar3007
-
Findlay DM. If good things come from above, do bad things come from below? Arthritis Res Ther. 2010;12(3):119.
-
(2010)
Arthritis Res Ther
, vol.12
, Issue.3
, pp. 119
-
-
Findlay, D.M.1
-
38
-
-
34548841961
-
Osteoporosis: Non-hormonal treatment
-
DOI 10.1080/13697130701600815, PII 782116853, The Proceedings of the 7th Workshop of the International Menopause Society
-
Rizzoli R. Osteoporosis: non-hormonal treatment. Climacteric. 2007;10 Suppl 2:74-8. (Pubitemid 47450832)
-
(2007)
Climacteric
, vol.10
, Issue.SUPPL. 2
, pp. 74-78
-
-
Rizzoli, R.1
-
39
-
-
0345257158
-
Bisphosphonates: Potential therapeutic agents for disease modification in osteoarthritis
-
Spector TD. Bisphosphonates: potential therapeutic agents for disease modification in osteoarthritis. Aging Clin Exp Res. 2003;15(5):413-8. (Pubitemid 37509166)
-
(2003)
Aging - Clinical and Experimental Research
, vol.15
, Issue.5
, pp. 413-418
-
-
Spector, T.D.1
-
40
-
-
27744441326
-
Effect of risedronate on joint structure and symptoms of knee osteoarthritis: Results of the BRISK randomized, controlled trial [ISRCTN01928173]
-
15899049 1:CAS:528:DC%2BD2MXkt1equ7Y%3D 10.1186/ar1716
-
Spector TD, Conaghan PG, Buckland-Wright JC, Garnero P, Cline GA, Beary JF, et al. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res Ther. 2005;7(3):R625-33.
-
(2005)
Arthritis Res Ther
, vol.7
, Issue.3
-
-
Spector, T.D.1
Conaghan, P.G.2
Buckland-Wright, J.C.3
Garnero, P.4
Cline, G.A.5
Beary, J.F.6
-
41
-
-
33750961447
-
Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: Results of the two-year multinational knee osteoarthritis structural arthritis study
-
DOI 10.1002/art.22160
-
Bingham 3rd CO, Buckland-Wright JC, Garnero P, Cohen SB, Dougados M, Adami S, et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum. 2006;54(11):3494-507. (Pubitemid 44737161)
-
(2006)
Arthritis and Rheumatism
, vol.54
, Issue.11
, pp. 3494-3507
-
-
Bingham III, C.O.1
Buckland-Wright, J.C.2
Garnero, P.3
Cohen, S.B.4
Dougados, M.5
Adami, S.6
Clauw, D.J.7
Spector, T.D.8
Pelletier, J.-P.9
Raynauld, J.-P.10
Strand, V.11
Simon, L.S.12
Meyer, J.M.13
Cline, G.A.14
Beary, J.F.15
-
42
-
-
34248547194
-
The futility of current approaches to chondroprotection
-
DOI 10.1002/art.22526
-
Felson DT, Kim YJ. The futility of current approaches to chondroprotection. Arthritis Rheum. 2007;56(5):1378-83. (Pubitemid 46764064)
-
(2007)
Arthritis and Rheumatism
, vol.56
, Issue.5
, pp. 1378-1383
-
-
Felson, D.T.1
Kim, Y.-J.2
-
43
-
-
79960432551
-
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis
-
21637997 1:CAS:528:DC%2BC3MXovVWis7g%3D 10.1007/s00223-011-9499-8
-
Rizzoli R, Reginster JY, Boonen S, Breart G, Diez-Perez A, Felsenberg D, et al. Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int. 2011;89(2):91-104.
-
(2011)
Calcif Tissue Int
, vol.89
, Issue.2
, pp. 91-104
-
-
Rizzoli, R.1
Reginster, J.Y.2
Boonen, S.3
Breart, G.4
Diez-Perez, A.5
Felsenberg, D.6
-
44
-
-
33750105854
-
Strontium ranelate for preventing and treating postmenopausal osteoporosis
-
CD005326 17054253
-
O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY. Strontium ranelate for preventing and treating postmenopausal osteoporosis. Cochrane Database Syst Rev. 2006;4, CD005326.
-
(2006)
Cochrane Database Syst Rev.
, vol.4
-
-
O'Donnell, S.1
Cranney, A.2
Wells, G.A.3
Adachi, J.D.4
Reginster, J.Y.5
-
45
-
-
84872091677
-
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: Results of a double-blind, randomised placebo-controlled trial
-
This study describes the results of a double-blind, randomised placebo-controlled clinical trial on the safety and efficacy of strontium ranelate for the treatment of knee OA
-
• Reginster JY, Badurski J, Bellamy N, Bensen W, Chapurlat R, Chevalier X, et al. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann Rheum Dis. 2013;72(2):179-86. This study describes the results of a double-blind, randomised placebo-controlled clinical trial on the safety and efficacy of strontium ranelate for the treatment of knee OA.
-
(2013)
Ann Rheum Dis.
, vol.72
, Issue.2
, pp. 179-186
-
-
Reginster, J.Y.1
Badurski, J.2
Bellamy, N.3
Bensen, W.4
Chapurlat, R.5
Chevalier, X.6
-
46
-
-
84878246667
-
Impact of treatments for osteoporosis on cartilage biomarkers in humans
-
1:CAS:528:DC%2BC38XhvVCks7nL 10.1007/s00198-012-2165-9
-
Richette P, Roux C. Impact of treatments for osteoporosis on cartilage biomarkers in humans. Osteoporos Int. 2012;23 Suppl 8:877-80.
-
(2012)
Osteoporos Int
, vol.23
, Issue.SUPPL. 8
, pp. 877-880
-
-
Richette, P.1
Roux, C.2
-
47
-
-
56849129748
-
The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis
-
17911037 1:CAS:528:DC%2BD1cXhsVKlsL%2FJ 10.1016/j.tvjl.2007.08.013
-
Sutton S, Clutterbuck A, Harris P, Gent T, Freeman S, Foster N, et al. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis. Vet J. 2009;179(1):10-24.
-
(2009)
Vet J
, vol.179
, Issue.1
, pp. 10-24
-
-
Sutton, S.1
Clutterbuck, A.2
Harris, P.3
Gent, T.4
Freeman, S.5
Foster, N.6
-
48
-
-
72849130196
-
Targeting matrix metalloproteinases in inflammatory conditions
-
19909233 1:CAS:528:DC%2BD1MXhsFGht7jE 10.2174/138945009789753264
-
Clutterbuck AL, Asplin KE, Harris P, Allaway D, Mobasheri A. Targeting matrix metalloproteinases in inflammatory conditions. Curr Drug Targets. 2009;10(12):1245-54.
-
(2009)
Curr Drug Targets
, vol.10
, Issue.12
, pp. 1245-1254
-
-
Clutterbuck, A.L.1
Asplin, K.E.2
Harris, P.3
Allaway, D.4
Mobasheri, A.5
-
49
-
-
33748757528
-
Role of nitric oxide and reactive oxygen species in arthritis
-
DOI 10.2174/138161206778343082
-
Cuzzocrea S. Role of nitric oxide and reactive oxygen species in arthritis. Curr Pharm Des. 2006;12(27):3551-70. (Pubitemid 44400492)
-
(2006)
Current Pharmaceutical Design
, vol.12
, Issue.27
, pp. 3551-3570
-
-
Cuzzocrea, S.1
-
50
-
-
54249104477
-
Nitric oxide in inflammation and pain associated with osteoarthritis
-
19007427 10.1186/ar2463 1:CAS:528:DC%2BD1MXmt1WjtQ%3D%3D
-
Abramson SB. Nitric oxide in inflammation and pain associated with osteoarthritis. Arthritis Res Ther. 2008;10 Suppl 2:S2.
-
(2008)
Arthritis Res Ther
, vol.10
, Issue.SUPPL. 2
, pp. 2
-
-
Abramson, S.B.1
-
51
-
-
0030662094
-
Nitric oxide and inflammatory arthritides
-
DOI 10.1016/S0024-3205(97)00585-7, PII S0024320597005857
-
Miyasaka N, Hirata Y. Nitric oxide and inflammatory arthritides. Life Sci. 1997;61(21):2073-81. (Pubitemid 27478834)
-
(1997)
Life Sciences
, vol.61
, Issue.21
, pp. 2073-2081
-
-
Miyasaka, N.1
Hirata, Y.2
-
52
-
-
40549139749
-
In vitro effects of diacerein on NO production by chondrocytes in response to proinflammatory mediators
-
18334727
-
de Isla NG, Mainard D, Muller S, Stoltz JF. In vitro effects of diacerein on NO production by chondrocytes in response to proinflammatory mediators. Biomed Mater Eng. 2008;18(1 Suppl):S99-S104.
-
(2008)
Biomed Mater Eng
, vol.18
, Issue.1 SUPPL.
-
-
De Isla, N.G.1
Mainard, D.2
Muller, S.3
Stoltz, J.F.4
-
54
-
-
84878476048
-
Tissue-specific implications of mitochondrial alterations in aging
-
Liu D, Li H, Lu J, Bai Y. Tissue-specific implications of mitochondrial alterations in aging. Front Biosci (Elite Ed). 2013;5:734-47.
-
(2013)
Front Biosci (Elite Ed)
, vol.5
, pp. 734-747
-
-
Liu, D.1
Li, H.2
Lu, J.3
Bai, Y.4
-
55
-
-
33748328353
-
Mitochondrial activity is modulated by TNF and IL-1 in normal human chondrocyte cells
-
DOI 10.1016/j.joca.2006.03.008, PII S1063458406000550
-
Lopez-Armada MJ, Carames B, Martin MA, Cillero-Pastor B, Lires-Dean M, Fuentes-Boquete I, et al. Mitochondrial activity is modulated by TNFalpha and IL-1beta in normal human chondrocyte cells. Osteoarthr Cartil. 2006;14(10):1011-22. (Pubitemid 44321373)
-
(2006)
Osteoarthritis and Cartilage
, vol.14
, Issue.10
, pp. 1011-1022
-
-
Lopez-Armada, M.J.1
Carames, B.2
Martin, M.A.3
Cillero-Pastor, B.4
Lires-Dean, M.5
Fuentes-Boquete, I.6
Arenas, J.7
Blanco, F.J.8
-
56
-
-
10644271561
-
Mitochondrial dysfunction in osteoarthritis
-
DOI 10.1016/j.mito.2004.07.022, PII S1567724904001606
-
Blanco FJ, Lopez-Armada MJ, Maneiro E. Mitochondrial dysfunction in osteoarthritis. Mitochondrion. 2004;4(5-6):715-28. (Pubitemid 39646817)
-
(2004)
Mitochondrion
, vol.4
, Issue.56 SPEC. ISSUE.
, pp. 715-728
-
-
Blanco, F.J.1
Lopez-Armada, M.J.2
Maneiro, E.3
-
57
-
-
77956271188
-
Aberrant mitochondrial homeostasis in the skeletal muscle of sedentary older adults
-
20520725 10.1371/journal.pone.0010778 1:CAS:528:DC%2BC3cXmslyjtLo%3D
-
Safdar A, Hamadeh MJ, Kaczor JJ, Raha S, Debeer J, Tarnopolsky MA. Aberrant mitochondrial homeostasis in the skeletal muscle of sedentary older adults. PLoS One. 2010;5(5):e10778.
-
(2010)
PLoS One
, vol.5
, Issue.5
, pp. 10778
-
-
Safdar, A.1
Hamadeh, M.J.2
Kaczor, J.J.3
Raha, S.4
Debeer, J.5
Tarnopolsky, M.A.6
-
58
-
-
0033939459
-
Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization
-
DOI 10.1002/1529-0131(200007) 43:7<1560::AID-ANR21>3.0.CO;2-S
-
Johnson K, Jung A, Murphy A, Andreyev A, Dykens J, Terkeltaub R. Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum. 2000;43(7):1560-70. (Pubitemid 30452477)
-
(2000)
Arthritis and Rheumatism
, vol.43
, Issue.7
, pp. 1560-1570
-
-
Johnson, K.1
Jung, A.2
Murphy, A.3
Andreyev, A.4
Dykens, J.5
Terkeltaub, R.6
-
59
-
-
79952451523
-
The role of mitochondria in osteoarthritis
-
21200395 1:CAS:528:DC%2BC3MXislOktbw%3D 10.1038/nrrheum.2010.213 This is a thought-provoking article that discusses the emerging role of mitochondria in OA
-
• Blanco FJ, Rego I, Ruiz-Romero C. The role of mitochondria in osteoarthritis. Nat Rev Rheumatol. 2011;7(3):161-9. This is a thought-provoking article that discusses the emerging role of mitochondria in OA.
-
(2011)
Nat Rev Rheumatol
, vol.7
, Issue.3
, pp. 161-169
-
-
Blanco, F.J.1
Rego, I.2
Ruiz-Romero, C.3
-
60
-
-
0037334593
-
Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes
-
DOI 10.1002/art.10837
-
Maneiro E, Martin MA, de Andres MC, Lopez-Armada MJ, Fernandez-Sueiro JL, del Hoyo P, et al. Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheum. 2003;48(3):700-8. (Pubitemid 36302006)
-
(2003)
Arthritis and Rheumatism
, vol.48
, Issue.3
, pp. 700-708
-
-
Maneiro, E.1
Martin, M.A.2
De Andres, M.C.3
Lopez-Armada, M.J.4
Fernandez-Sueiro, J.L.5
Del Hoyo, P.6
Galdo, F.7
Arenas, J.8
Blanco, F.J.9
-
61
-
-
25144461499
-
Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes
-
15987486 10.1186/ar1752 1:CAS:528:DC%2BD2MXls1Gjurs%3D
-
Da Sylva TR, Connor A, Mburu Y, Keystone E, Wu GE. Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes. Arthritis Res Ther. 2005;7(4):R844-51.
-
(2005)
Arthritis Res Ther
, vol.7
, Issue.4
-
-
Da Sylva, T.R.1
Connor, A.2
Mburu, Y.3
Keystone, E.4
Wu, G.E.5
-
62
-
-
57349106464
-
Diminished mitochondrial DNA integrity and repair capacity in OA chondrocytes
-
18562218 1:STN:280:DC%2BD1M%2FhsVKmsw%3D%3D 10.1016/j.joca.2008.05.009
-
Grishko VI, Ho R, Wilson GL, Pearsall AW 4th. Diminished mitochondrial DNA integrity and repair capacity in OA chondrocytes. Osteoarthr Cartil. 2009;17(1):107-13.
-
(2009)
Osteoarthr Cartil
, vol.17
, Issue.1
, pp. 107-113
-
-
Grishko, V.I.1
Ho, R.2
Wilson, G.L.3
Pearsall VI, A.W.4
-
63
-
-
76549113814
-
Mitochondrial DNA damage is involved in apoptosis caused by pro-inflammatory cytokines in human OA chondrocytes
-
19822235 1:STN:280:DC%2BC3c7kvFOlsw%3D%3D 10.1016/j.joca.2009.09.008
-
Kim J, Xu M, Xo R, Mates A, Wilson GL, Pearsall AW 4th. Mitochondrial DNA damage is involved in apoptosis caused by pro-inflammatory cytokines in human OA chondrocytes. Osteoarthr Cartil. 2010;18(3):424-32.
-
(2010)
Osteoarthr Cartil
, vol.18
, Issue.3
, pp. 424-432
-
-
Kim, J.1
Xu, M.2
Xo, R.3
Mates, A.4
Wilson, G.L.5
Pearsall VI, A.W.6
-
64
-
-
1842683010
-
Mediation of Spontaneous Knee Osteoarthritis by Progressive Chondrocyte ATP Depletion in Hartley Guinea Pigs
-
DOI 10.1002/art.20149
-
Johnson K, Svensson CI, Etten DV, Ghosh SS, Murphy AN, Powell HC, et al. Mediation of spontaneous knee osteoarthritis by progressive chondrocyte ATP depletion in Hartley guinea pigs. Arthritis Rheum. 2004;50(4):1216-25. (Pubitemid 38480832)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.4
, pp. 1216-1225
-
-
Johnson, K.1
Svensson, C.I.2
Van Etten, D.3
Ghosh, S.S.4
Murphy, A.N.5
Powell, H.C.6
Terkeltaub, R.7
-
65
-
-
34447328099
-
Reactive oxygen species and superoxide dismutases: Role in joint diseases
-
DOI 10.1016/j.jbspin.2007.02.002, PII S1297319X07001595
-
Afonso V, Champy R, Mitrovic D, Collin P, Lomri A. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine. 2007;74(4):324-9. (Pubitemid 47049827)
-
(2007)
Joint Bone Spine
, vol.74
, Issue.4
, pp. 324-329
-
-
Afonso, V.1
Champy, R.2
Mitrovic, D.3
Collin, P.4
Lomri, A.5
-
66
-
-
0028263767
-
Glutathione-ascorbic acid antioxidant system in animals
-
Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem. 1994;269(13):9397-400. (Pubitemid 24196524)
-
(1994)
Journal of Biological Chemistry
, vol.269
, Issue.13
, pp. 9397-9400
-
-
Meister, A.1
-
67
-
-
0028273316
-
Glutathione, ascorbate, and cellular protection
-
Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res. 1994;54(7 Suppl):1969s-75s. (Pubitemid 24132158)
-
(1994)
Cancer Research
, vol.54
, Issue.7 SUPPL.
-
-
Meister, A.1
-
68
-
-
77955436218
-
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease
-
20511611 1:CAS:528:DC%2BC3cXhtVyktL7O 10.1136/ard.2009.119966
-
Scott JL, Gabrielides C, Davidson RK, Swingler TE, Clark IM, Wallis GA, et al. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis. 2010;69(8):1502-10.
-
(2010)
Ann Rheum Dis
, vol.69
, Issue.8
, pp. 1502-1510
-
-
Scott, J.L.1
Gabrielides, C.2
Davidson, R.K.3
Swingler, T.E.4
Clark, I.M.5
Wallis, G.A.6
-
69
-
-
59149096239
-
Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: A decrease in mitochondrial superoxide dismutase points to a redox imbalance
-
18784066 1:CAS:528:DC%2BD1MXpsFCjsg%3D%3D 10.1074/mcp.M800292-MCP200
-
Ruiz-Romero C, Calamia V, Mateos J, Carreira V, Martinez-Gomariz M, Fernandez M, et al. Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance. Mol Cell Proteomics. 2009;8(1):172-89.
-
(2009)
Mol Cell Proteomics
, vol.8
, Issue.1
, pp. 172-189
-
-
Ruiz-Romero, C.1
Calamia, V.2
Mateos, J.3
Carreira, V.4
Martinez-Gomariz, M.5
Fernandez, M.6
-
70
-
-
0035988302
-
Role of chondrocyte death and hypocellularity in ageing human articular cartilage and the pathogenesis of osteoarthritis
-
DOI 10.1054/mehy.2000.1180
-
Mobasheri A. Role of chondrocyte death and hypocellularity in ageing human articular cartilage and the pathogenesis of osteoarthritis. Med Hypotheses. 2002;58(3):193-7. (Pubitemid 34664889)
-
(2002)
Medical Hypotheses
, vol.58
, Issue.3
, pp. 193-197
-
-
Mobasheri, A.1
-
71
-
-
0041382662
-
Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis
-
DOI 10.1016/S1090-0233(02)00331-3, PII S1090023302003313
-
Goggs R, Carter SD, Schulze-Tanzil G, Shakibaei M, Mobasheri A. Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis. Vet J. 2003;166(2):140-58. (Pubitemid 37554969)
-
(2003)
Veterinary Journal
, vol.166
, Issue.2
, pp. 140-158
-
-
Goggs, R.1
Carter, S.D.2
Schulze-Tanzil, G.3
Shakibaei, M.4
Mobasheri, A.5
-
72
-
-
84865626752
-
Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes
-
22549761 1:CAS:528:DC%2BC38Xht1GrsbnM 10.1002/art.34508
-
Vaamonde-Garcia C, Riveiro-Naveira RR, Valcarcel-Ares MN, Hermida-Carballo L, Blanco FJ, Lopez-Armada MJ. Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes. Arthritis Rheum. 2012;64(9):2927-36.
-
(2012)
Arthritis Rheum
, vol.64
, Issue.9
, pp. 2927-2936
-
-
Vaamonde-Garcia, C.1
Riveiro-Naveira, R.R.2
Valcarcel-Ares, M.N.3
Hermida-Carballo, L.4
Blanco, F.J.5
Lopez-Armada, M.J.6
-
73
-
-
49449087136
-
Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes
-
18668543 1:CAS:528:DC%2BD1cXhtVCjtbfI 10.1002/art.23644
-
Cillero-Pastor B, Carames B, Lires-Dean M, Vaamonde-Garcia C, Blanco FJ, Lopez-Armada MJ. Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis Rheum. 2008;58(8):2409-19.
-
(2008)
Arthritis Rheum
, vol.58
, Issue.8
, pp. 2409-2419
-
-
Cillero-Pastor, B.1
Carames, B.2
Lires-Dean, M.3
Vaamonde-Garcia, C.4
Blanco, F.J.5
Lopez-Armada, M.J.6
-
74
-
-
84857142257
-
Osteoarthritis year 2011 in review: Biology
-
22179031 1:STN:280:DC%2BC383ksFGhsQ%3D%3D 10.1016/j.joca.2011.11.015
-
Lotz M. Osteoarthritis year 2011 in review: biology. Osteoarthr Cartil. 2012;20(3):192-6.
-
(2012)
Osteoarthr Cartil
, vol.20
, Issue.3
, pp. 192-196
-
-
Lotz, M.1
-
75
-
-
84856264222
-
MtDNA haplogroup J modulates telomere length and nitric oxide production
-
22171676 1:CAS:528:DC%2BC38Xis12ntLw%3D 10.1186/1471-2474-12-283
-
Fernandez-Moreno M, Tamayo M, Soto-Hermida A, Mosquera A, Oreiro N, Fernandez-Lopez C, et al. mtDNA haplogroup J modulates telomere length and nitric oxide production. BMC Musculoskelet Disord. 2011;12:283.
-
(2011)
BMC Musculoskelet Disord
, vol.12
, pp. 283
-
-
Fernandez-Moreno, M.1
Tamayo, M.2
Soto-Hermida, A.3
Mosquera, A.4
Oreiro, N.5
Fernandez-Lopez, C.6
-
76
-
-
84874108083
-
Seven sirtuins for seven deadly diseases of aging
-
This is a general review that discusses the role of sirtiuns in diseases associated with aging
-
• Morris BJ. Seven sirtuins for seven deadly diseases of aging. Free Radic Biol Med. 2013;56:133-71. This is a general review that discusses the role of sirtiuns in diseases associated with aging.
-
(2013)
Free Radic Biol Med
, vol.56
, pp. 133-171
-
-
Morris, B.J.1
-
77
-
-
51849141393
-
The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production
-
18759268 10.1002/art.23799
-
Dave M, Attur M, Palmer G, Al-Mussawir HE, Kennish L, Patel J, et al. The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production. Arthritis Rheum. 2008;58(9):2786-97.
-
(2008)
Arthritis Rheum
, vol.58
, Issue.9
, pp. 2786-2797
-
-
Dave, M.1
Attur, M.2
Palmer, G.3
Al-Mussawir, H.E.4
Kennish, L.5
Patel, J.6
-
78
-
-
84860148618
-
Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health
-
22605974 1:CAS:528:DC%2BC38Xlsl2rtro%3D 10.3390/ijms13044202
-
Mobasheri A, Henrotin Y, Biesalski HK, Shakibaei M. Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health. Int J Mol Sci. 2012;13(4):4202-32.
-
(2012)
Int J Mol Sci
, vol.13
, Issue.4
, pp. 4202-4232
-
-
Mobasheri, A.1
Henrotin, Y.2
Biesalski, H.K.3
Shakibaei, M.4
-
79
-
-
84869233544
-
Intersection of inflammation and herbal medicine in the treatment of osteoarthritis
-
22987043 10.1007/s11926-012-0288-9
-
Mobasheri A. Intersection of inflammation and herbal medicine in the treatment of osteoarthritis. Curr Rheumatol Rep. 2012;14(6):604-16.
-
(2012)
Curr Rheumatol Rep
, vol.14
, Issue.6
, pp. 604-616
-
-
Mobasheri, A.1
-
80
-
-
33748484703
-
Understanding the role of tissue degrading enzymes and their inhibitors in development and disease
-
DOI 10.1016/j.berh.2006.06.007, PII S1521694206000751
-
Cawston TE, Wilson AJ. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Pract Res Clin Rheumatol. 2006;20(5):983-1002. (Pubitemid 44356460)
-
(2006)
Best Practice and Research: Clinical Rheumatology
, vol.20
, Issue.5
, pp. 983-1002
-
-
Cawston, T.E.1
Wilson, A.J.2
-
81
-
-
0030715322
-
ECM and cell surface proteolysis: Regulating cellular ecology
-
Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 1997;91(4):439-42. (Pubitemid 27508232)
-
(1997)
Cell
, vol.91
, Issue.4
, pp. 439-442
-
-
Werb, Z.1
-
82
-
-
0037693895
-
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry
-
DOI 10.1161/01.RES.0000070112.80711.3D
-
Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92(8):827-39. (Pubitemid 36542523)
-
(2003)
Circulation Research
, vol.92
, Issue.8
, pp. 827-839
-
-
Visse, R.1
Nagase, H.2
-
83
-
-
35348964525
-
Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage
-
10.1186/ar2013 1:CAS:528:DC%2BD28XovVKms78%3D
-
Davidson R, Waters J, Kevorkian L, Darrah C, Cooper A, Donell S, et al. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther. 2006;8(4):124.
-
(2006)
Arthritis Res Ther
, vol.8
, Issue.4
, pp. 124
-
-
Davidson, R.1
Waters, J.2
Kevorkian, L.3
Darrah, C.4
Cooper, A.5
Donell, S.6
-
84
-
-
70249124544
-
Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis
-
16919164 10.1186/ar2034 1:CAS:528:DC%2BD28XhtVSjsL7O
-
Milner J, Rowan A, Cawston T, Young D. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis. Arthritis Res Ther. 2006;8(5):R142.
-
(2006)
Arthritis Res Ther
, vol.8
, Issue.5
, pp. 142
-
-
Milner, J.1
Rowan, A.2
Cawston, T.3
Young, D.4
-
85
-
-
0034253761
-
Mechanisms involved in cartilage proteoglycan catabolism
-
DOI 10.1016/S0945-053X(00)00078-0, PII S0945053X00000780
-
Caterson B, Flannery CR, Hughes C, Little CB. Mechanisms involved in cartilage proteoglycan catabolism. Matrix Biol. 2000;19:333-44. (Pubitemid 30665657)
-
(2000)
Matrix Biology
, vol.19
, Issue.4
, pp. 333-344
-
-
Caterson, B.1
Flannery, C.R.2
Hughes, C.E.3
Little, C.B.4
-
86
-
-
0031025218
-
Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
-
DOI 10.1074/jbc.272.4.2446
-
Ohuchi E, Imai K, Fujii Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem. 1997;72:2446-51. (Pubitemid 27058534)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.4
, pp. 2446-2451
-
-
Ohuchi, E.1
Imai, K.2
Fujii, Y.3
Sato, H.4
Seiki, M.5
Okada, Y.6
-
87
-
-
0030030879
-
Biochemical characterization of human collagenase-3
-
DOI 10.1074/jbc.271.3.1544
-
Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical Characterization of Human Collagenase-3. J Biol Chem. 1996;271(3):1544-50. (Pubitemid 26028643)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.3
, pp. 1544-1550
-
-
Knauper, V.1
Lopez-Otin, C.2
Smith, B.3
Knight, G.4
Murphy, G.5
-
88
-
-
1542495378
-
Proteolysis of the collagen fibril in osteoarthritis
-
Poole AR, Nelson F, Dahlberg L, Tchetina E, Kobayashi M, Yasuda T, et al. Proteolysis of the collagen fibril in osteoarthritis. Biochem Soc Symp. 2003;70:115-23. (Pubitemid 38497220)
-
(2003)
Biochemical Society Symposium
, Issue.70
, pp. 115-123
-
-
Poole, A.R.1
Nelson, F.2
Dahlberg, L.3
Tchetina, E.4
Kobayashi, M.5
Yasuda, T.6
Laverty, S.7
Squires, G.8
Kojima, T.9
Wu, W.10
Billinghurst, R.C.11
-
89
-
-
77950022355
-
Effects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritis
-
20067755 1:STN:280:DC%2BC3c3itF2qsg%3D%3D 10.1016/j.joca.2009.12.006
-
Mapp PI, Walsh DA, Bowyer J, Maciewicz RA. Effects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritis. Osteoarthr Cartil. 2010;18(4):593-600.
-
(2010)
Osteoarthr Cartil
, vol.18
, Issue.4
, pp. 593-600
-
-
Mapp, P.I.1
Walsh, D.A.2
Bowyer, J.3
Maciewicz, R.A.4
-
90
-
-
78851472303
-
Clinical trials of resveratrol
-
21261655 1:CAS:528:DC%2BC3MXjsFOltr4%3D 10.1111/j.1749-6632.2010.05853.x
-
Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K. Clinical trials of resveratrol. Ann N Y Acad Sci. 2011;1215:161-9.
-
(2011)
Ann N y Acad Sci
, vol.1215
, pp. 161-169
-
-
Patel, K.R.1
Scott, E.2
Brown, V.A.3
Gescher, A.J.4
Steward, W.P.5
Brown, K.6
-
91
-
-
32644449009
-
Complementary or alternative therapies for osteoarthritis
-
DOI 10.1038/ncprheum0093, PII N0093
-
Ernst E. Complementary or alternative therapies for osteoarthritis. Nat Clin Pract Rheumatol. 2006;2(2):74-80. (Pubitemid 43239206)
-
(2006)
Nature Clinical Practice Rheumatology
, vol.2
, Issue.2
, pp. 74-80
-
-
Ernst, E.1
-
92
-
-
4344603557
-
Musculoskeletal conditions and complementary/alternative medicine
-
DOI 10.1016/j.berh.2004.03.005, PII S1521694204000464
-
Ernst E. Musculoskeletal conditions and complementary/alternative medicine. Best Pract Res Clin Rheumatol. 2004;18(4):539-56. (Pubitemid 39145061)
-
(2004)
Best Practice and Research: Clinical Rheumatology
, vol.18
, Issue.4
, pp. 539-556
-
-
Ernst, E.1
-
93
-
-
0037372784
-
Complementary medicine
-
DOI 10.1097/00002281-200303000-00012
-
Ernst E. Complementary medicine. Curr Opin Rheumatol. 2003;15(2):151-5. (Pubitemid 36250297)
-
(2003)
Current Opinion in Rheumatology
, vol.15
, Issue.2
, pp. 151-155
-
-
Ernst, E.1
-
94
-
-
0034534408
-
Complementary and alternative medicine in rheumatology
-
DOI 10.1053/berh.2000.0110
-
Ernst E. Complementary and alternative medicine in rheumatology. Baillieres Best Pract Res Clin Rheumatol. 2000;14(4):731-49. (Pubitemid 32010915)
-
(2000)
Best Practice and Research in Clinical Rheumatology
, vol.14
, Issue.4
, pp. 731-749
-
-
Ernst, E.1
-
95
-
-
19544390715
-
Herbal medications commonly used in the practice of rheumatology: Mechanisms of action, efficacy, and side effects
-
DOI 10.1016/j.semarthrit.2005.01.011, PII S0049017205000120
-
Setty AR, Sigal LH. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin Arthritis Rheum. 2005;34(6):773-84. (Pubitemid 40732452)
-
(2005)
Seminars in Arthritis and Rheumatism
, vol.34
, Issue.6
, pp. 773-784
-
-
Setty, A.R.1
Sigal, L.H.2
-
96
-
-
84868641456
-
Current nutraceuticals in the management of osteoarthritis: A review
-
22850529 1:CAS:528:DC%2BC38XhtFSitrzI 10.1177/1759720X11436238
-
Akhtar N, Haqqi TM. Current nutraceuticals in the management of osteoarthritis: a review. Ther Adv Musculoskelet Dis. 2012;4(3):181-207.
-
(2012)
Ther Adv Musculoskelet Dis
, vol.4
, Issue.3
, pp. 181-207
-
-
Akhtar, N.1
Haqqi, T.M.2
-
97
-
-
0034900221
-
Herbal medicines for the treatment of osteoarthritis: A systematic review
-
1:STN:280:DC%2BD3MvksFehtw%3D%3D 10.1093/rheumatology/40.7.779
-
Long L, Soeken K, Ernst E. Herbal medicines for the treatment of osteoarthritis: a systematic review. Rheumatology (Oxford). 2001;40(7):779-93.
-
(2001)
Rheumatology (Oxford)
, vol.40
, Issue.7
, pp. 779-793
-
-
Long, L.1
Soeken, K.2
Ernst, E.3
-
98
-
-
0842327467
-
Combination anti-inflammatory therapy: Synergism in rats of NSAIDs/corticosteroids with some herbal/animal products
-
DOI 10.1163/156856003322699636
-
Whitehouse MW, Butters DE. Combination anti-inflammatory therapy: synergism in rats of NSAIDs/corticosteroids with some herbal/animal products. Inflammopharmacology. 2003;11(4):453-64. (Pubitemid 38175954)
-
(2003)
Inflammopharmacology
, vol.11
, Issue.4-6
, pp. 453-464
-
-
Whitehouse, M.W.1
Butters, D.E.2
-
99
-
-
74549220692
-
Why is osteoarthritis an age-related disease?
-
20129196 1:STN:280:DC%2BC3c7htFWkug%3D%3D 10.1016/j.berh.2009.08.006
-
Shane Anderson A, Loeser RF. Why is osteoarthritis an age-related disease? Best Pract Res Clin Rheumatol. 2010;24(1):15-26.
-
(2010)
Best Pract Res Clin Rheumatol
, vol.24
, Issue.1
, pp. 15-26
-
-
Shane Anderson, A.1
Loeser, R.F.2
-
100
-
-
0035100888
-
-
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
-
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89-95.
-
(2001)
Clin Pharmacol Ther
, vol.69
, Issue.3
, pp. 89-95
-
-
-
101
-
-
79955846044
-
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis
-
21396468 1:STN:280:DC%2BC3MrgvFGquw%3D%3D 10.1016/j.joca.2010.08.019 This excellent article by the OARSI FDA Osteoarthritis Biomarkers Working Group discusses how biomarkers can lead to an improved understanding of the molecular processes in OA and how they may facilitate the process of drug discovery
-
•• Kraus VB, Burnett B, Coindreau J, Cottrell S, Eyre D, Gendreau M, et al. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthr Cartil. 2011;19(5):515-42. This excellent article by the OARSI FDA Osteoarthritis Biomarkers Working Group discusses how biomarkers can lead to an improved understanding of the molecular processes in OA and how they may facilitate the process of drug discovery.
-
(2011)
Osteoarthr Cartil
, vol.19
, Issue.5
, pp. 515-542
-
-
Kraus, V.B.1
Burnett, B.2
Coindreau, J.3
Cottrell, S.4
Eyre, D.5
Gendreau, M.6
-
102
-
-
0035037328
-
Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: Criteria, validation, strategies
-
DOI 10.1146/annurev.pharmtox.41.1.347
-
Lesko LJ, Atkinson Jr AJ. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol. 2001;41:347-66. (Pubitemid 32390116)
-
(2001)
Annual Review of Pharmacology and Toxicology
, vol.41
, pp. 347-366
-
-
Lesko, L.J.1
Atkinson Jr., A.J.2
-
103
-
-
50649122963
-
The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon?
-
18590824 1:CAS:528:DC%2BD1cXhtVygtLbN 10.1016/j.phrs.2008.06.001
-
Qvist P, Bay-Jensen AC, Christiansen C, Dam EB, Pastoureau P, Karsdal MA. The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon? Pharmacol Res. 2008;58(1):1-7.
-
(2008)
Pharmacol Res
, vol.58
, Issue.1
, pp. 1-7
-
-
Qvist, P.1
Bay-Jensen, A.C.2
Christiansen, C.3
Dam, E.B.4
Pastoureau, P.5
Karsdal, M.A.6
-
104
-
-
84871921917
-
Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)
-
This elegant paper by Berenbaum highlights the fact that OA is an inflammatory disease
-
•• Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2013;21(1):16-21. This elegant paper by Berenbaum highlights the fact that OA is an inflammatory disease.
-
(2013)
Osteoarthritis Cartilage
, vol.21
, Issue.1
, pp. 16-21
-
-
Berenbaum, F.1
-
105
-
-
84871438042
-
Potassium channels in articular chondrocytes
-
1:CAS:528:DC%2BC3sXivFeitbo%3D 10.4161/chan.22340
-
Mobasheri A, Lewis R, Ferreira-Mendes A, Rufino A, Dart C, Barrett-Jolley R. Potassium channels in articular chondrocytes. Channels (Austin). 2012;6(6):416-25.
-
(2012)
Channels (Austin)
, vol.6
, Issue.6
, pp. 416-425
-
-
Mobasheri, A.1
Lewis, R.2
Ferreira-Mendes, A.3
Rufino, A.4
Dart, C.5
Barrett-Jolley, R.6
-
106
-
-
84867868437
-
Osteoarthritis year 2012 in review: Biomarkers
-
22842200 1:STN:280:DC%2BC38fjsl2lsg%3D%3D 10.1016/j.joca.2012.07.009
-
Mobasheri A. Osteoarthritis year 2012 in review: biomarkers. Osteoarthr Cartil. 2012;20(12):1451-64.
-
(2012)
Osteoarthr Cartil
, vol.20
, Issue.12
, pp. 1451-1464
-
-
Mobasheri, A.1
-
109
-
-
67649467338
-
Therapeutic targets for osteoarthritis
-
19423245 1:CAS:528:DC%2BD1MXotFClsbc%3D 10.1016/j.maturitas.2009.03.015
-
Edmonds S. Therapeutic targets for osteoarthritis. Maturitas. 2009;63(3):191-4. Research Council
-
(2009)
Maturitas
, vol.63
, Issue.3
, pp. 191-194
-
-
Edmonds, S.1
|